Health TrialsbyHealthPanel

Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia

ConditionsPneumoniaPneumonia, Ventilator-AssociatedLength of Stay
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse

About this trial

Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult

Patient living at home or in an institution

Patient hospitalized for less than 48 hours

respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and

Disqualifiers

Pneumonia acquired at the hospital.

Patient hospitalized in another department more than 48 hours before admission

Chronic respiratory failure

Active neoplasia

Trial design

Design model

Parallel

Treatments tested in this trial

  • O2 automated

    Device

    In the "O2 automated" group, patients benefit from oxygen therapy via the "FreeO2" device. The O2 saturation target is set by the clinician on the device. Saturation is continuously sensed by an oximeter and the oxygen flow is automatically adjusted. The clinician has access to instantaneous values and trends of O2 and SpO2 flow rates.

  • O2 standard

    Device

    In the "O2 standard" group, patients benefit from oxygen therapy with nasal goggles or a high concentration mask. Saturation is continuously captured by an oximeter. The flow rate of oxygen, evaluated in L/min, is adapted according to local protocols (every 8 hours in conventional hospital services, continuous in intensive care

Treatment groups

128 Participants
are divided into 2 treatment groups
Group A: Automated oxygen therapyOther 1 intervention
Group B: Standard Oxygen therapyOther 1 intervention

Trial outcomes

Primary outcomes

1

Length in days of hospital stay

measure of total days of hospitalization and intensive care

Time frame
1 month

Secondary outcomes

1

Duration of oxygen therapy

Oxygen therapy time evaluation during hospitalization of patient

Time frame
1 month
2

Time spent outside of the target saturation

Investigator want evaluate the time spent outside of the target saturation by patient, during their hospitalization,

Time frame
1 month
3

the cost on the medical-economic level

investigator want evaluate the cost of hospitalization between patient in arm "Automated oxygen therapy" and patient in arm "Standard Oxygen therapy"

Time frame
1 month
4

rate of medical complication

Investigator want to evaluate the rate of medical complication between patient in arm "Automated oxygen therapy" and patient in arm "Standard Oxygen therapy"

Time frame
1 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Toulouse

Lead sponsor

Source ClinicalTrials.gov
Apply now